Armistice Capital, LLC Immunocore Holdings PLC Transaction History

Armistice Capital, LLC

$6.02 Billion
Q3 2024

A detailed history of Armistice Capital, LLC transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Armistice Capital, LLC holds 1,264,000 shares of IMCR stock, worth $41 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

1,264,000

Previous 976,000 29.51%

Holding current value

$41 Million

Previous $33.1 Million 18.96%

% of portfolio

0.65%

Previous 0.43%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$30.06 - $41.49 $8.66 Million - $11.9 Million	288,000 Added 29.51%	1,264,000 $39.3 Million
Q2 2024 Aug 14, 2024	BUY	$33.78 - $63.75 $27.4 Million - $51.8 Million	812,000 Added 495.12%	976,000 $33.1 Million
Q1 2024 May 15, 2024	SELL	$60.14 - $75.36 $8.9 Million - $11.2 Million	-148,000 Reduced 47.44%	164,000 $10.7 Million
Q4 2023 Feb 13, 2024	SELL	$42.85 - $69.5 $3.77 Million - $6.12 Million	-88,000 Reduced 22.0%	312,000 $21.3 Million
Q3 2023 Nov 14, 2023	SELL	$49.5 - $66.6 $1.39 Million - $1.86 Million	-28,000 Reduced 6.54%	400,000 $20.8 Million
Q2 2023 Aug 14, 2023	BUY	$48.54 - $61.64 $2.43 Million - $3.08 Million	50,000 Added 13.23%	428,000 $25.7 Million
Q1 2023 May 15, 2023	BUY	$46.12 - $65.71 $1.94 Million - $2.76 Million	42,000 Added 12.5%	378,000 $18.7 Million
Q4 2022 Feb 14, 2023	BUY	$45.51 - $65.08 $910,200 - $1.3 Million	20,000 Added 6.33%	336,000 $19.2 Million
Q3 2022 Nov 14, 2022	BUY	$37.34 - $57.44 $1.79 Million - $2.76 Million	48,000 Added 17.91%	316,000 $14.8 Million
Q2 2022 Aug 15, 2022	BUY	$25.46 - $37.72 $2.24 Million - $3.32 Million	88,000 Added 48.89%	268,000 $10 Million
Q1 2022 May 16, 2022	BUY	$18.94 - $34.29 $3.41 Million - $6.17 Million	180,000 New	180,000 $5.38 Million

Others Institutions Holding IMCR

# of Institutions

141

Shares Held

41.4M

Call Options Held

197K

Put Options Held

451K

View Full List

About Immunocore Holdings plc

Ticker IMCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,897,100
Market Cap $1.42B
Description
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...

More about IMCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.

Account

Armistice Capital, LLC Immunocore Holdings PLC Transaction History